Back to Search
DENNIS HILLIARD, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1659355691IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
G33679(CA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF CALIFORNIA, DAVIS SCHOOL OF MEDICINE
Class of 1980
Research & Publications (10)
Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.
PMID 18580870·Clin Pharmacol Ther·2008
2-rct
Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects.
PMID 18434566·J Clin Pharmacol·2008
4-observational
Pharmacokinetics, pharmacodynamics, and safety of a prostaglandin D2 receptor antagonist.
PMID 17882161·Clin Pharmacol Ther·2008
4-observational
Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet.
PMID 17925592·J Clin Pharmacol·2007
4-observational
A high-precision fluorogenic cholesteryl ester transfer protein assay compatible with animal serum and 3456-well assay technology.
PMID 17601482·Anal Biochem·2007
7-preclinical
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.
PMID 16912128·J Clin Endocrinol Metab·2006
4-observational
Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects.
PMID 16855072·J Clin Pharmacol·2006
4-observational
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
PMID 16490580·Clin Ther·2006
2-rct
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses.
PMID 16338283·Clin Pharmacol Ther·2005
2-rct
Allosteric activators of glucokinase: potential role in diabetes therapy.
PMID 12869762·Science·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 401 E HIGHLAND AVE, C
SAN BERNARDINO, CA 92404 - Phone
- (909) 886-6806
Quick Facts
- NPI
- 1659355691
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 46
- Publications
- 10
Are you this provider?
Claim Your Profile